Why are not There More Bayesian Clinical Trials? Perceived Barriers and Educational Preferences Among Medical Researchers Involved in Drug Development

OBJECTIVE AND BACKGROUND: The clinical trials community has been hesitant to adopt Bayesian statistical methods, which are often more flexible and efficient with more naturally interpretable results than frequentist methods. We aimed to identify self-reported barriers to implementing Bayesian method...

Descripción completa

Detalles Bibliográficos
Autores principales: Clark, Jennifer, Muhlemann, Natalia, Natanegara, Fanni, Hartley, Andrew, Wenkert, Deborah, Wang, Fei, Harrell, Frank E., Bray, Ross
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Analytical Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720547/
https://www.ncbi.nlm.nih.gov/pubmed/34978048
http://dx.doi.org/10.1007/s43441-021-00357-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720547/
https://www.ncbi.nlm.nih.gov/pubmed/34978048
http://dx.doi.org/10.1007/s43441-021-00357-x

Ejemplares similares